StockIQpro
NYSE:EDVA

Endovia Health Sciences, Inc.

Track all markets on TradingView
Track all markets on TradingView

Endovia Health Sciences, Inc.'s revenue fell 90.9% in fiscal 2025 to $73,066 while operating margin fell to −19415.6%. The diluted share count rose 62.8%.Summary generated from Endovia Health Sciences, Inc.'s SEC filings. Latest annual report filed Apr 15, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)$73,066
Revenue growth−90.9%
Revenue, 5-yr CAGR−49.8%
Gross margin23.1%
Operating margin−19415.6%
Net margin−34537.0%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+62.8%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue11181910
Operating income−29−21−15−10−14
Net income−29−22−21−24−25
Free cash flow−15−14−10−7n/a

Recent filings

From SEC EDGAR

Peers

Beverages